Search

everythinglearnresearchcommunity

for

Search:↓

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

Presurgical models can effectively and affordably screen cancer prevention agents.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

The document concludes that identifying the specific cells where skin cancers begin is important for creating better prevention, detection, and treatment methods.

Five molecular elements identified as potential future targets for hair loss therapy.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

Plucked hair can effectively monitor drug effects in cancer treatment.

The UD-PrOZA program successfully diagnosed 18% of adult patients with rare diseases, often using genetic testing.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Suppressing ODC activity reduces tumor growth in hair follicles.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

HOTTIP and miR-10b may be targeted to improve glioma treatment by reducing resistance to chemotherapy.

Human melanocytes have unique traits that affect melanoma development and prognosis.

The conclusion is that a certain test might help find cancer spread in lymph nodes for melanoma patients, but more research is needed due to false positives.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

Targeting SOX proteins may improve cancer treatment by restoring immune function.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

Soy foods may lower colon cancer risk.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Nanocarriers can improve skin treatments after cancer therapy by enhancing antioxidant delivery and effectiveness.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

Single-cell transcriptomics reveals detailed cellular diversity and key pathways in tissue regeneration.

Different body areas have unique skin cell communication patterns, explaining why certain skin diseases occur in specific regions.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Tumor proteins can both promote and suppress cancer, depending on the situation.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.